Arbutus Biopharma Corp (ABUS)
2.71
+0.03
(+1.12%)
USD |
NASDAQ |
May 03, 16:00
2.715
0.00 (0.00%)
Pre-Market: 20:00
Arbutus Biopharma 1 Year Total Returns (Daily): 7.97% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 7.97% |
| May 02, 2024 | 8.06% |
| May 01, 2024 | 6.75% |
| April 30, 2024 | 8.76% |
| April 29, 2024 | 10.76% |
| April 26, 2024 | 7.91% |
| April 25, 2024 | 7.51% |
| April 24, 2024 | -4.84% |
| April 23, 2024 | -8.33% |
| April 22, 2024 | -12.00% |
| April 19, 2024 | -9.33% |
| April 18, 2024 | -7.46% |
| April 17, 2024 | -5.12% |
| April 16, 2024 | 1.74% |
| April 15, 2024 | 3.48% |
| April 12, 2024 | 3.56% |
| April 11, 2024 | 4.12% |
| April 10, 2024 | 3.83% |
| April 09, 2024 | 4.70% |
| April 08, 2024 | 7.67% |
| April 05, 2024 | 7.59% |
| April 04, 2024 | 0.33% |
| April 03, 2024 | -4.58% |
| April 02, 2024 | -16.83% |
| April 01, 2024 | -15.51% |
| Date | Value |
|---|---|
| March 28, 2024 | -14.00% |
| March 27, 2024 | -15.03% |
| March 26, 2024 | -17.00% |
| March 25, 2024 | -17.00% |
| March 22, 2024 | -15.25% |
| March 21, 2024 | -15.84% |
| March 20, 2024 | -15.56% |
| March 19, 2024 | -16.39% |
| March 18, 2024 | -15.05% |
| March 15, 2024 | -13.53% |
| March 14, 2024 | -13.86% |
| March 13, 2024 | -8.78% |
| March 12, 2024 | -3.93% |
| March 11, 2024 | -2.86% |
| March 08, 2024 | -7.46% |
| March 07, 2024 | -7.85% |
| March 06, 2024 | -4.86% |
| March 05, 2024 | -6.64% |
| March 04, 2024 | -5.24% |
| March 01, 2024 | -0.71% |
| February 29, 2024 | 0.72% |
| February 28, 2024 | 3.60% |
| February 27, 2024 | 10.19% |
| February 26, 2024 | 10.19% |
| February 23, 2024 | 6.57% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.24%
Minimum
Oct 07 2019
272.5%
Maximum
Apr 05 2021
1.82%
Average
-11.90%
Median
Jan 11 2024
1 Year Total Returns (Daily) Benchmarks
| Moderna Inc | -3.95% |
| Pacira BioSciences Inc | -36.90% |
| Chimerix Inc | -15.67% |
| Karyopharm Therapeutics Inc | -69.13% |
| Corvus Pharmaceuticals Inc | 69.91% |